Inchinkoto, an herbal medicine, exerts beneficial effects in the rat liver under stress with hepatic ischemia-reperfusion and subsequent hepatectomy

Annals of Surgery

Volumn 251, Issue 4, 2010, Pages 692-700

  Kawai, Kiyotaka ^a   Yokoyama, Yukihiro ^a   Kokuryo, Toshio ^a   Watanabe, Katsutaka ^a   Kitagawa, Tomomi ^a   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GENIPIN; INCHINKOTO; INDUCIBLE NITRIC OXIDE SYNTHASE; LIVER PROTECTIVE AGENT; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CLAMP; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HEPATODUODENAL LIGAMENT; INFLAMMATION; LAPAROTOMY; LIGAMENT; LIVER INJURY; LIVER ISCHEMIA; LIVER RESECTION; MALE; MORTALITY; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UPREGULATION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CYTOKINES; DRUGS, CHINESE HERBAL; GLUTATHIONE; HEPATECTOMY; INFLAMMATION MEDIATORS; IRIDOIDS; LIVER; MALE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SURVIVAL RATE; TRANSAMINASES; TYROSINE;

EID: 77950862080     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181d50299     Document Type: Article

References (52)

1. Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg. 1998;5:402-408.
2. Bilzer M, Jaeschke H, Vollmar AM, et al. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol. 1999; 276:G1137-G1144.
3. Tsuji K, Kwon AH, Yoshida H, et al. Free radical scavenger (edaravone) prevents endotoxin-induced liver injury after partial hepatectomy in rats. J Hepatol. 2005;42:94-101. (Pubitemid 40038906)
4. Suzuki F, Hashikura Y, Ise H, et al. MCI-186 (edaravone), a free radical scavenger, attenuates hepatic warm ischemia-reperfusion injury in rats. Transpl Int. 2005;18:844-853.
5. Kobayashi M, Takeyoshi I, Yoshinari D, et al. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery. 2002;131:344-349.
6. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology. 1991;13:364-375.
7. Kurose I, Argenbright LW, Wolf R, et al. Ischemia/reperfusion-induced microvascular dysfunction: role of oxidants and lipid mediators. Am J Physiol. 1997;272:H2976-H2982.
8. Engerson TD, McKelvey TG, Rhyne DB, et al. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J Clin Invest. 1987;79: 1564-1570.
9. Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58:87-114.
10. Ma TT, Ischiropoulos H, Brass CA. Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion. Gastroenterology. 1995;108:463-469.
11. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315-424.
12. Bradham CA, Stachlewitz RF, Gao W, et al. Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein ki-nases. Hepatology. 1997;25:1128-1135.
13. Uehara T, Bennett B, Sakata ST, et al. JNK mediates hepatic ischemia reperfusion injury. J Hepatol. 2005;42:850-859.
14. Massip-Salcedo M, Casillas-Ramirez A, Franco-Gou R, et al. Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers. Am J Pathol. 2006;168:1474-1485.
15. Kim BJ, Ryu SW, Song BJ. JNK-and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem. 2006;281:21256-21265.
16. Yamamoto M, Miura N, Ohtake N, et al. Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice. Gastroenterology. 2000;118:380-389.
17. Yamamoto M, Ogawa K, Morita M, et al. The herbal medicine Inchin-ko-to inhibits liver cell apoptosis induced by transforming growth factor beta 1. Hepatology. 1996;23:552-559.
18. Kobayashi H, Horikoshi K, Yamataka A, et al. Beneficial effect of a traditional herbal medicine (inchin-ko-to) in postoperative biliary atresia patients. Pediatr Surg Int. 2001;17:386-389.
19. Shoda J, Miura T, Utsunomiya H, et al. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver. Hepatology. 2004;39:167-178.
20. Watanabe S, Yokoyama Y, Oda K, et al. Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma. Hepatol Res. 2009;39:247-255.
21. Okada K, Shoda J, Kano M, et al. Inchinkoto, a herbal medicine, and its ingredients dually exert Mrp2/MRP2-mediated choleresis and Nrf2-mediated antioxidative action in rat livers. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1450-G1463.
22. Kawai T, Yokoyama Y, Kawai S, et al. Does estrogen contribute to the hepatic regeneration following portal branch ligation in rats? Am J Physiol Gastrointest Liver Physiol. 2007;292:G582-G589.
23. Whiteman M, Siau JL, Halliwell B. Lack of tyrosine nitration by hypochlo-rous acid in the presence of physiological concentrations of nitrite. Implications for the role of nitryl chloride in tyrosine nitration in vivo. J Biol Chem. 2003;278:8380-8384.
24. Takayama Y, Kokuryo T, Yokoyama Y, et al. MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth. Cancer Lett. 2008;264:241-249.
25. Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev. 1992;127:25-50.
26. Satriano J. Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article. Amino Acids. 2004;26:321-329.
27. Miyasaka N, Hirata Y. Nitric oxide and inflammatory arthritides. Life Sci. 1997;61:2073-2081.
28. Ortega A, Carretero J, Obrador E, et al. Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels. Nitric Oxide. 2008;19:107-114.
29. Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci. 2000;21:249-252.
30. Hur GM, Ryu YS, Yun HY, et al. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappaB. Biochem Biophys Res Commun. 1999;261:917-922.
31. Akao T, Kobashi K, Aburada M. Enzymic studies on the animal and intestinal bacterial metabolism of geniposide. Biol Pharm Bull. 1994;17:1573-1576.
32. Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739-746.
33. Cursio R, Filippa N, Miele C, et al. Involvement of protein kinase B and mitogen-activated protein kinases in experimental normothermic liver isch-aemia-reperfusion injury. Br J Surg. 2006;93:752-761.
34. Lentsch AB, Kato A, Yoshidome H, et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32:169-173. (Pubitemid 30614647)
35. Fukai M, Hayashi T, Yokota R, et al. Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. Free Radic Biol Med. 2005;38:1372-1381.
36. Meguro M, Katsuramaki T, Nagayama M, et al. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfu-sion injury in the pig liver. Transplantation. 2002;73:1439-1446.
37. Ahmad N, Chen LC, Gordon MA, et al. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J Leukoc Biol. 2002;71:1005-1011.
38. Liang J, Yamaguchi Y, Matsumura F, et al. Calcium-channel blocker attenuates Kupffer cell production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion in rat liver. Dig Dis Sci. 2000;45:201-209.
39. Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg. 2001;181:160-166.
40. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284: G15-G26. (Pubitemid 36076246)
41. Curran RD, Billiar TR, Stuehr DJ, et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg. 1990;212:462-469.
42. Nussler AK, Di Silvio M, Billiar TR, et al. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med. 1992;176:261-264.
43. Geller DA, de Vera ME, Russell DA, et al. A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J Immunol. 1995;155:4890-4898.
44. Tiberio L, Tiberio GA, Bardella L, et al. Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver. Cytokine. 2006;34: 131-142.
45. Parks DA, Bulkley GB, Granger DN. Role of oxygen-derived free radicals in digestive tract diseases. Surgery. 1983;94:415-422.
46. Zhou W, Zhang Y, Hosch MS, et al. Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion. Hepatology. 2001;33:902-914.
47. Haddad IY, Pataki G, Hu P, et al. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest. 1994;94:2407-2413.
48. Shibuki H, Katai N, Yodoi J, et al. Lipid peroxidation and peroxynitrite in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci. 2000;41: 3607-3614.
49. Zhuang S, Simon G. Peroxynitrite-induced apoptosis involves activation of multiple caspases in HL-60 cells. Am J Physiol Cell Physiol. 2000;279:C341-C351.
50. Takamatsu Y, Shimada K, Yamaguchi K, et al. Inhibition of inducible nitric oxide synthase prevents hepatic, but not pulmonary, injury following isch-emia-reperfusion of rat liver. Dig Dis Sci. 2006;51:571-579.
51. Huang W, Zhang J, Moore DD. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest. 2004;113:137-143.
52. Chu CY, Tseng TH, Hwang JM, et al. Protective effects of capillarisin on tert-butylhydroperoxide-induced oxidative damage in rat primary hepato-cytes. Arch Toxicol. 1999;73:263-268.